The type III secretion system (T3SS) is a pivotal virulence mechanism of many Gram-negative bacteria. During infection, the syringe-like T3SS injects cytotoxic proteins directly into the eukaryotic host cell cytoplasm. In Pseudomonas aeruginosa, expression of the T3SS is regulated by a signaling cascade involving the proteins ExsA, ExsC, ExsD, and ExsE. The AraC-type transcription factor ExsA activates transcription of all T3SS-associated genes. Prior to host cell contact, ExsA is inhibited through direct binding of the anti-activator protein ExsD. Host cell contact triggers secretion of ExsE and sequestration of ExsD by ExsC to cause the release of ExsA. ExsA does not bind ExsD through the canonical ligand binding pocket of AraC-type proteins. Using site-directed mutagenesis and a specific in vitro transcription assay, we have now discovered that backbone interactions between the amino terminus of ExsD and the ExsA beta barrel constitute a pivotal part of the ExsD-ExsA interface. follow-up bacterial two-hybrid experiments suggest additional contacts create an even larger proteinprotein interface. The discovered role of the amino terminus of ExsD in ExsA binding explains how ExsC might relieve the ExsD-mediated inhibition of T3SS gene expression, because the same region of ExsD interacts with ExsC following host cell contact. Pseudomonas aeruginosa is a ubiquitous Gram-negative bacterium that causes opportunistic infections in many organisms including humans 1,2. P. aeruginosa accounts for an estimated 13% of all intensive care unit infections in the United States 3. P. aeruginosa-associated pneumonia has a mortality rate of nearly 50% 4 , while chronic lung infections caused by P. aeruginosa are the leading cause of mortality among cystic fibrosis patients 5,6. The type III secretion system (T3SS) has emerged as a key virulence determinant of acute infections 4. This secretion apparatus acts like a complex molecular syringe to transport four well-characterized toxins, ExoS, ExoT, ExoU, and ExoY, directly from the cytosol of the bacterial cell into the eukaryotic host cytoplasm 7-9. Their respective effects include disruption of the host cell actin cytoskeleton, inhibition of host cell cytokinesis, phospholipase-induced cell death, and inhibition of phagocytosis 7-9. Transcription of the effector genes and the structural and regulatory components of the T3SS is controlled through a number of regulatory mechanisms 10-12. A cascade involving the four proteins ExsA, ExsC, ExsD, and ExsE has been shown to mechanistically link host cell contact with upregulation of T3SS-related promoters by the transcriptional activator ExsA 13-21. Prior to infection, ExsA is inhibited by ExsD through the formation of a 1:1 complex that prevents ExsA homo-dimerization and promoter binding, while the T3SS chaperone ExsC is sequestered by the 81 amino acid protein ExsE 17,19. Upon host cell contact, ExsE is translocated into the host cell. Following secretion of ExsE, the liberated ExsC protein sequesters ExsD, which enables ExsA to bin...